Welcome to the News and Info section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed about the latest news and ongoing activities of the organization. This section contains announcements, press releases, and e-newsletters. See below for news coverage.
We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.
MRI Outperforms 3-D Mammograms In Detecting Cancer In Women With Dense Breasts NPR All Things Considered February 25, 2020
The results of Arm Z1D in the NCI-MATCH trial continue to attract media attention. Nilofer Azad, MD (Johns Hopkins) talks about the activity of nivolumab in MMR-deficient cancers in a February 20, 2020, feature article in MedPage Today/ASCO Reading Room February 02, 2020
Progress in Breast Cancer: What would Bill think? At a recent medical meeting, Joseph Sparano, MD (Albert Einstein/ Montefiore) asked what the late pioneer, William McGuire, MD, might have thought of the newest research advancements. Daniel Hayes, MD (University of Michigan) remarks in a video interview, with MedPage Today. February 18, 2020
Brian P. Schneider, MD (Indiana University) and fellow ECOG-ACRIN researchers aim to personalize chemotherapy for black women with breast cancer in a new trial, EAZ171, which is evaluating ways to reduce neuropathy, a painful side effect of chemotherapy treatments Healio HemOnc Today January 27, 2020
Ahmad Tarhini, MD (Moffitt Cancer Center) on the results of the E1609 study: “For the first time in our knowledge in melanoma adjuvant therapy, this study has demonstrated a significant improvement in overall survival against an active control regimen.” The ASCO Post January 15, 2020
Al B. Benson III was appointed deputy chair for policy and implementation The Cancer Letter January 17, 2020
San Antonio Breast Cancer Symposium honors ECOG-ACRIN vice chair Joseph A. Sparano, MD with its prestigious William L. McGuire Memorial Lecture Award More Here December 01, 2020
ASCO updates guidelines for early breast cancer based on TAILORx, MINDACT trials Cancer Network July 1, 2019
One Year Post-TAILORx: Attitudes Shift and Questions Linger in Breast Cancer Recurrence Testing GenomeWeb May 31, 2019 (requires free registration)
Using Genomic Profiling to Guide Treatment Decisions for ER-Positive Breast Cancers, by Harold J. Burstein, MD, PhD CancerNetwork May 28, 2019
New TAILORx Data Provide Treatment Guidance for Women Under 50 With Early Breast Cancer The ASCO Post June 13, 2019
No benefit from pazopanib in advanced kidney cancer after surgery to remove metastases Medical Xpress June 3, 2019